For the Inventor, By the Inventor

Enter assignee name

Potomac, MD, United States of America

Sequoia Pharmaceuticals, Inc.

USPTO Granted Patents = 20

CIPO Patents = 2

EPO Patents = 3

Forward Citations = 47

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Michael Eissenstat (19 out of 26 patents)

Dehui Duan (12 out of 12 patents)

John W Erickson (4 out of 20 patents)

4. Ji-Hye Kang (3 out of 3 patents)

5. Andrey Topin (2 out of 2 patents)

6. Greg Delahanty (2 out of 2 patents)

7. Gnana Ravi Rajendran (2 out of 2 patents)

8. Abelardo Silva (2 out of 3 patents)

9. Pavel Majer (1 out of 27 patents)

10. Sergei V Gulnik (1 out of 6 patents)

11. Jihye Kang (1 out of 1 patent)

12. Sergi Gulnik (1 out of 1 patent)

13. Rongjuan Lu (1 out of 1 patent)

14. Tatiana Guerassina (1 out of 1 patent)

20 patents: Sort by Forward Citations

1. 9849107 - Compositions and methods for inhibiting cytochrome P450 (2017-12-26),

2. 9604952 - Compositions and methods for inhibiting cytochrome P450 2D6 (2017-03-28),

3. 9540354 - Diamide inhibitors of cytochrome P450 (2017-01-10),

4. 9403789 - Benzofuran-containing amino acid inhibitors of cytochrome P450 (2016-08-02),

5. 9233952 - Compositions and methods for inhibiting cytochrome P450 (2016-01-12),

6. 8952056 - Methods for inhibiting drug degradation (2015-02-10),

7. 8906647 - Diamide inhibitors of cytochrome P450 (2014-12-09),

8. 8791157 - 5-substituted benzofurans as inhibitors of cytochrome P450 2D6 (2014-07-29),

9. 8703700 - Bimacrocylic HCV NS3 protease inhibitors (2014-04-22),

10. 8673970 - HIV protease inhibitor and cytochrome p450 inhibitor combinations (2014-03-18),

11. 8569364 - 5-substituted benzofurans as inhibitors of cytochrome P450 2D6 (2013-10-29),

12. 8481520 - Compositions and methods for inhibiting cytochrome P450 (2013-07-09),

13. 8389571 - Benzofuran derived HIV protease inhibitors (2013-03-05),

14. 8048871 - Compositions and methods for inhibiting cytochrome P450 (2011-11-01),

15. 7981929 - Benzofuran derived HIV protease inhibitors (2011-07-19),

Sequoia Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative antiviral therapeutics. With a diverse pipeline of potential treatments, Sequoia aims to address unmet medical needs in viral infections. By utilizing groundbreaking research and cutting-edge technology, the company is dedicated to advancing the field of antiviral drug development.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

20 Patents

#3 in Potomac, MD

#205 in Maryland

#15,886 in US

#30,349 in the World

Potomac, MD, United States of America

Sequoia Pharmaceuticals, Inc.

Forward Citations = 47

14 inventors:

Michael Eissenstat (19 out of 26 patents)

Dehui Duan (12 out of 12 patents)

John W Erickson (4 out of 20 patents)

4. Ji-Hye Kang (3 out of 3 patents)

5. Andrey Topin (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com

Loading…